vs
FIRST MERCHANTS CORP（FRME）与GLAUKOS Corp（GKOS）财务数据对比。点击上方公司名可切换其他公司
FIRST MERCHANTS CORP的季度营收约是GLAUKOS Corp的1.0倍（$157.1M vs $150.6M），FIRST MERCHANTS CORP净利率更高（17.9% vs 6.2%，领先11.7%），过去两年GLAUKOS Corp的营收复合增速更高（25.4% vs -0.9%）
第一商人集团是总部位于美国印第安纳州曼西的金融控股公司，业务覆盖印第安纳州中部地区，旗下拥有第一商人银行、第一商人私人财富顾问两大板块，在纳斯达克上市，股票代码为FRME。截至2023年3月，集团总资产达182亿美元，为客户提供商业银行、个人银行及投资顾问服务。
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
FRME vs GKOS — 直观对比
营收规模更大
FRME
是对方的1.0倍
$150.6M
净利率更高
FRME
高出11.7%
6.2%
两年增速更快
GKOS
近两年复合增速
-0.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $157.1M | $150.6M |
| 净利润 | $28.2M | $9.4M |
| 毛利率 | — | 77.9% |
| 营业利润率 | — | 9.0% |
| 净利率 | 17.9% | 6.2% |
| 营收同比 | — | 41.2% |
| 净利润同比 | -49.1% | — |
| 每股收益（稀释后） | $0.45 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FRMEGKOS
| Q1 26 | $157.1M | $150.6M | ||
| Q4 25 | $172.2M | $143.1M | ||
| Q3 25 | $166.1M | $133.5M | ||
| Q2 25 | $164.3M | $124.1M | ||
| Q1 25 | $160.3M | $106.7M | ||
| Q4 24 | $177.1M | $105.5M | ||
| Q3 24 | $156.0M | $96.7M | ||
| Q2 24 | $159.9M | $95.7M |
净利润FRMEGKOS
| Q1 26 | $28.2M | $9.4M | ||
| Q4 25 | $57.1M | $-133.7M | ||
| Q3 25 | $56.8M | $-16.2M | ||
| Q2 25 | $56.8M | $-19.7M | ||
| Q1 25 | $55.3M | $-18.1M | ||
| Q4 24 | $64.3M | $-33.6M | ||
| Q3 24 | $49.2M | $-21.4M | ||
| Q2 24 | $39.9M | $-50.5M |
毛利率FRMEGKOS
| Q1 26 | — | 77.9% | ||
| Q4 25 | — | -1.1% | ||
| Q3 25 | — | 78.4% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 77.2% | ||
| Q4 24 | — | 72.9% | ||
| Q3 24 | — | 76.6% | ||
| Q2 24 | — | 76.4% |
营业利润率FRMEGKOS
| Q1 26 | — | 9.0% | ||
| Q4 25 | 38.0% | -97.7% | ||
| Q3 25 | 39.3% | -12.3% | ||
| Q2 25 | 39.6% | -18.3% | ||
| Q1 25 | 39.4% | -19.4% | ||
| Q4 24 | 43.3% | -27.2% | ||
| Q3 24 | 36.1% | -25.5% | ||
| Q2 24 | 27.5% | -31.3% |
净利率FRMEGKOS
| Q1 26 | 17.9% | 6.2% | ||
| Q4 25 | 33.1% | -93.4% | ||
| Q3 25 | 34.2% | -12.2% | ||
| Q2 25 | 34.6% | -15.8% | ||
| Q1 25 | 34.5% | -17.0% | ||
| Q4 24 | 36.3% | -31.8% | ||
| Q3 24 | 31.5% | -22.1% | ||
| Q2 24 | 25.0% | -52.8% |
每股收益（稀释后）FRMEGKOS
| Q1 26 | $0.45 | — | ||
| Q4 25 | $0.98 | $-2.34 | ||
| Q3 25 | $0.98 | $-0.28 | ||
| Q2 25 | $0.98 | $-0.34 | ||
| Q1 25 | $0.94 | $-0.32 | ||
| Q4 24 | $1.09 | $-0.56 | ||
| Q3 24 | $0.84 | $-0.39 | ||
| Q2 24 | $0.68 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $276.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $670.9M |
| 总资产 | $21.1B | $893.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FRMEGKOS
| Q1 26 | — | $276.7M | ||
| Q4 25 | — | $90.8M | ||
| Q3 25 | — | $98.2M | ||
| Q2 25 | — | $100.8M | ||
| Q1 25 | — | $114.3M | ||
| Q4 24 | — | $169.6M | ||
| Q3 24 | — | $100.1M | ||
| Q2 24 | — | $68.1M |
股东权益FRMEGKOS
| Q1 26 | $2.7B | $670.9M | ||
| Q4 25 | $2.5B | $656.2M | ||
| Q3 25 | $2.4B | $769.5M | ||
| Q2 25 | $2.3B | $765.1M | ||
| Q1 25 | $2.3B | $764.0M | ||
| Q4 24 | $2.3B | $766.9M | ||
| Q3 24 | $2.3B | $668.5M | ||
| Q2 24 | $2.2B | $665.2M |
总资产FRMEGKOS
| Q1 26 | $21.1B | $893.3M | ||
| Q4 25 | $19.0B | $893.5M | ||
| Q3 25 | $18.8B | $999.4M | ||
| Q2 25 | $18.6B | $987.0M | ||
| Q1 25 | $18.4B | $966.2M | ||
| Q4 24 | $18.3B | $974.8M | ||
| Q3 24 | $18.3B | $926.5M | ||
| Q2 24 | $18.3B | $919.7M |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRME
| Net Interest Income | $151.3M | 96% |
| Noninterest Income | $5.8M | 4% |
GKOS
暂无分部数据
